News
Journey Medical Corporation (NASDAQ: DERM) Q1 2025 Earnings Call Transcript May 14, 2025 Journey Medical Corporation beats ...
With a narrative that continues to grow and become increasingly complex, Phase 5 features a variety of stories spread out ...
On top of that, you get to choose between three different versions, the Nintendo Switch, Nintendo Switch ... especially as folks are trying to disconnect from the TV and phone even more.
Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ETCompany ParticipantsHeath Sampson - CEO, President, Interim ...
We're looking forward to starting the Phase 2 study in Fragile X syndrome later this year with MRM-3379 and completing enrollment of the LIVMARLI Phase 3 EXPAND ... on LIVMARLI switch to tablet.
Operator: Welcome to GSI Technologies Fourth Quarter and Fiscal Year 2025 Results Conference Call. At this time, all ...
Phase 2A of Mumbai Metro Line 3—also called the Aqua Line—is now in its final stage. This new stretch will connect Bandra-Kurla Complex (BKC) to Acharya Atre Chowk in Worli. As per the Free Press ...
no evidence of lymphopenia or CD4 cell count reduction was observed with the islatravir component. Only 2% to 3% of patients discontinued due to adverse events, indicating good tolerability.
These version 3.3 Phase 1 Banners start on Wednesday 21st May and are expected to end on Wednesday 11th June. These version 3.3 Phase 2 Banners are expected to run from Wednesday 11th June to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results